EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Modulating the gut microenvironment as a treatment strategy for irritable bowel syndrome: a narrative review

Cristina Iribarren, Lujain Maasfeh, Lena Öhman, Magnus Simrén iD

Gut Microbiome · 2022

DOI: 10.1017/gmb.2022.6 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Gut Microbiome, 2022. Verfasst von Cristina Iribarren und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Medical Research Council, Sahlgrenska Academy at University of Gothenburg, ALF-agreement.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Irritable bowel syndrome (IBS) is a disorder of gut–brain interaction with a complex pathophysiology. Growing evidence suggests that alterations of the gut microenvironment, including microbiota composition and function, may be involved in symptom generation. Therefore, attempts to modulate the gut microenvironment have provided promising results as an indirect approach for IBS management. Antibiotics, probiotics, prebiotics, food and faecal microbiota transplantation are the main strategies for alleviating IBS symptom severity by modulating gut microbiota composition and function (eg. metabolism), gut barrier integrity and immune activity, although with varying efficacy. In this narrative review, we aim to provide an overview of the current approaches targeting the gut microenvironment in order to indirectly manage IBS symptoms.

Schlagwörter

Stichwörter der Autor:innen

Antibioticsdietary habitsfaecal microbiota transplantationirritable bowel syndromeprebioticsprobiotics

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Center for Functional GI and Motility Disorders, University of North Carolina, Chapel Hill, NC, USA.

ORCID-Profile: Magnus Simrén

Förderung

  • Swedish Medical Research Council
  • Sahlgrenska Academy at University of Gothenburg
  • ALF-agreement
  • Regional Executive Board, Region Västra Götaland
  • Faculty of Medicine at University of Gothenburg

Zitieren

APA

Iribarren, C., Maasfeh, L., Öhman, L., & Simrén, M. (2022). Modulating the gut microenvironment as a treatment strategy for irritable bowel syndrome: a narrative review. Gut Microbiome. https://doi.org/10.1017/gmb.2022.6

Vancouver

Iribarren C, Maasfeh L, Öhman L, Simrén M. Modulating the gut microenvironment as a treatment strategy for irritable bowel syndrome: a narrative review. Gut Microbiome. 2022. doi:10.1017/gmb.2022.6

BibTeX
@article{Iribarren2022,
  author = {Iribarren, Cristina and Maasfeh, Lujain and Öhman, Lena and Simrén, Magnus},
  title = {Modulating the gut microenvironment as a treatment strategy for irritable bowel syndrome: a narrative review},
  journal = {Gut Microbiome},
  year = {2022},
  doi = {10.1017/gmb.2022.6}
}
Kostenlos starten →